Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gabriela Brückner
Observed name:
Brückner, Gabriela
Institution:
Wissenschaftliches Institut der AOK
Observed institution:
Wissenschaftliches Institut der AOK
ORCID:
0009-0000-4464-5351
Observed ORCID:
0009-0000-4464-5351
OpenAlex ID:
A5026875055
The burden of disease in Germany at the national and regional level—results in terms of disability-adjusted life years (DALY) from the BURDEN 2020 study
2022
·
Michael Porst
, Elena von der Lippe
, et al.
·
Deutsches Ärzteblatt international
·
65
BURDEN 2020—Burden of disease in Germany at the national and regional level
2018
·
Alexander Rommel
, Elena von der Lippe
, et al.
·
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
·
45
PDF
Schätzung kleinräumiger Krankheitshäufigkeiten für die deutsche Bevölkerung anhand von Routinedaten am Beispiel von Typ-2-Diabetes
2019
·
Jan Breitkreuz
, Gabriela Brückner
, et al.
·
AStA Wirtschafts- und Sozialstatistisches Archiv
·
19
PDF
High risk for life-threatening adverse events of fluoroquinolones in young adults: a large German population-based cohort study
2025
·
Julia Wicherski
, Jonas Peltner
, et al.
·
BMC Medicine
·
18
PDF
N-Nitrosodimethylamine-Contaminated Valsartan and the Risk of Cancer
2021
·
Willy Gomm
, Christoph Röthlein
, et al.
·
Deutsches Ärzteblatt international
·
16
Nutzung von Krankenkassenroutinedaten zur Bestimmung von Krankheitshäufigkeiten im Projekt BURDEN 2020
2022
·
Katrin Schüssel
, Jan Breitkreuz
, et al.
·
Das Gesundheitswesen
·
11
PDF
Occupational risks of COVID-19: a case-cohort study using health insurance claims data in Germany
2024
·
Karla Romero Starke
, René Mauer
, et al.
·
BMC Public Health
·
5
Association between fluoroquinolones and retinal detachment: insights from a large German health claims-based cohort study
2025
·
Julia Wicherski
, Jonas Peltner
, et al.
·
BMC Ophthalmology
·
4
PDF
Fluoroquinolones and the risk of aortic aneurysm or dissection: A population‐based propensity score‐matched German cohort study
2025
·
Julia Wicherski
, Jonas Peltner
, et al.
·
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
·
4
PDF
Fluoroquinolone‐Associated Peripheral and Central Nervous System‐Related Disorders: A Large German Claims‐Based Cohort Study
2026
·
Julia Wicherski
, Jonas Peltner
, et al.
·
European Journal of Neurology
·
1
Erratum to: BURDEN 2020—Burden of disease in Germany at the national and regional level
2018
·
Alexander Rommel
, Elena von der Lippe
, et al.
·
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
·
1
Fluoroquinolone-Associated Injuries of Tendon, Muscles and Synovium: Recent Evidence From a Large German Claims Data Cohort Study
2026
·
Julia Wicherski
, Jonas Peltner
, et al.
·
Drugs & Therapy Perspectives
PDF
Gesundheitsatlas Deutschland - Herzinsuffizienz
2026
·
Ashrafian, Sarah
, Schüssel, Katrin
, et al.
·
Fachrepositorium Lebenswissenschaften
B2B Marketing Attribution Challenges
2026
·
Brückner, Gabriela
, bruce, gabriely
·
Zenodo (CERN European Organization for Nuclear Research)
Forecast of dementia prevalence in Germany and subnational regions until 2060 using microsimulation
2026
·
Katrin Schüssel
, Gabriela Brückner
, et al.
·
European Journal of Epidemiology
PDF
Survival impact of the Cologne Network Genomic Medicine in advanced non-small-cell lung cancer on the population level: real-world evidence for the effectiveness of precision oncology
2026
·
Anna Kron
, Kilson Moon
, et al.
·
SSRN Electronic Journal
PDF
Temporal changes in occupational risks of COVID-19 hospitalisation in Germany, 2020–2021: a case–cohort study
2025
·
Karla Romero Starke
, René Mauer
, et al.
·
BMJ Public Health
PDF
Show more works
View as search
Works count:
35
Citation count:
199
H-index:
6
I10-index:
6
Year
Topic
Type